Ergoloid Mesylates

Product NDC: 53489-281
11-digit product format: 534890281
Labeler code: 53489
Product ID: 53489-281_273c1270-5303-44f5-be30-0c779d88fea1
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Dihydroergocornine Mesylate, Dihydroergocristine Mesylate, Dihydro-.alpha.-ergocryptine mesylate, and Dihydro-.beta.-ergocryptine mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Sun Pharmaceutical Industries, Inc.
Application: ANDA081113
Marketing category: ANDA
Marketing start: 1991-10-31
Marketing end: 0000-00-00
Substance: DIHYDROERGOCORNINE MESYLATE; DIHYDROERGOCRISTINE MESYLATE; DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE; DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE
Active strength: 0 mg/1; mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 2020-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 6 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	53489-281		D	Discontinued by firm	2026-08-03
excluded package	package	53489-281	53489-281-01	D	Discontinued by firm	2026-08-03
excluded package	package	53489-281	53489-281-02	D	Discontinued by firm	2026-08-03
excluded package	package	53489-281	53489-281-03	D	Discontinued by firm	2026-08-03
excluded package	package	53489-281	53489-281-05	D	Discontinued by firm	2026-08-03
excluded package	package	53489-281	53489-281-10	D	Discontinued by firm	2026-08-03

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53489-281-02	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53489-281-03	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53489-281-10	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53489-281-01	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	53489-281-05	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53489-281-02	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53489-281-03	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53489-281-10	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53489-281-01	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	53489-281-05	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53489-281-02	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53489-281-03	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53489-281-10	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53489-281-01	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	53489-281-05	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53489-281-02	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53489-281-03	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53489-281-10	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53489-281-01	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	53489-281-05	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53489-281-02	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53489-281-03	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53489-281-10	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53489-281-01	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	53489-281-05	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53489-281-02	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53489-281-03	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53489-281-10	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53489-281-01	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	53489-281-05	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53489-281-02	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53489-281-03	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53489-281-10	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53489-281-01	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	53489-281-05	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53489-281-02	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53489-281-03	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53489-281-10	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53489-281-01	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	53489-281-05	`ed331223b511…`	`672a5bd82f5f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A081113-001	ERGOLOID MESYLATES	ERGOLOID MESYLATES	1MG	TABLET / ORAL			1991-10-31

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 41 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	RLD / RS	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL		1991-10-31	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`e64feba35796…`
2022-07-09 03:26 UTC · 3 captures of this ZIP	2022-07	A081113-001	ERGOLOID MESYLATES	1MG	TABLET / ORAL	RS	1991-10-31	`cb3db0bc1861…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
594e2c86-3079-4e6e-96c9-48f7a8afc78d	Product name	1	20230718
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
53489-281-01	EA - Each	53489-281	873a4465-0244-462f-8cb1-f84d0b549b54	1	2012-07-24

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
Dihydro-.alpha.-ergocryptine mesylate	ACTIVE INGREDIENT	Z4I7BU58DN	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydro-.beta.-ergocryptine mesylate	ACTIVE INGREDIENT	79Y4U49I29	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydroergocornine Mesylate	ACTIVE INGREDIENT	42RX8KPW29	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydroergocristine Mesylate	ACTIVE INGREDIENT	DS7CL18UAM	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydro-.alpha.-ergocryptine	ACTIVE MOIETY	202229IR8Y	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydroergocornine	ACTIVE MOIETY	IK4C1OC8NE	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydroergocristine	ACTIVE MOIETY	05D48LUM4Z	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Epicriptine	ACTIVE MOIETY	5M64643B5U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
butylated hydroxyanisole	INACTIVE INGREDIENT	REK4960K2U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
hydrogenated cottonseed oil	INACTIVE INGREDIENT	Z82Y2C65EA	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
lactose	INACTIVE INGREDIENT	J2B2A4N98G	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
mannitol	INACTIVE INGREDIENT	3OWL53L36A	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
povidone k90	INACTIVE INGREDIENT	RDH86HJV5Z	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
starch, corn	INACTIVE INGREDIENT	O8232NY3SJ	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
stearic acid	INACTIVE INGREDIENT	4ELV7Z65AP	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
talc	INACTIVE INGREDIENT	7SEV7J4R1U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [MUTUAL PHARMACEUTICAL COMPANY, INC.]	3
Dihydro-.alpha.-ergocryptine mesylate	ACTIVE INGREDIENT	Z4I7BU58DN	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydro-.beta.-ergocryptine mesylate	ACTIVE INGREDIENT	79Y4U49I29	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydroergocornine Mesylate	ACTIVE INGREDIENT	42RX8KPW29	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydroergocristine Mesylate	ACTIVE INGREDIENT	DS7CL18UAM	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydro-.alpha.-ergocryptine	ACTIVE MOIETY	202229IR8Y	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydroergocornine	ACTIVE MOIETY	IK4C1OC8NE	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Dihydroergocristine	ACTIVE MOIETY	05D48LUM4Z	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
Epicriptine	ACTIVE MOIETY	5M64643B5U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
HYDROGENATED COTTONSEED OIL	INACTIVE INGREDIENT	Z82Y2C65EA	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
POVIDONE K90	INACTIVE INGREDIENT	RDH86HJV5Z	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
STEARIC ACID	INACTIVE INGREDIENT	4ELV7Z65AP	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	ERGOLOID MESYLATES (DIHYDROERGOCORNINE MESYLATE, DIHYDROERGOCRISTINE MESYLATE, DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE, AND DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE) TABLET [CARILION MATERIALS MANAGEMENT]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
42RX8KPW29	DIHYDROERGOCORNINE MESYLATE	29261-94-7	DIHYDROERGOCORNINE MESYLATE
DS7CL18UAM	DIHYDROERGOCRISTINE MESYLATE	24730-10-7	DIHYDROERGOCRISTINE MESYLATE
Z4I7BU58DN	DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE	14271-05-7	DIHYDRO-.ALPHA.-ERGOCRYPTINE MESYLATE
79Y4U49I29	DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE	65914-79-6	DIHYDRO-.BETA.-ERGOCRYPTINE MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
318179	ergoloid mesylates 1 MG Oral Tablet	PSN	1344cf98-7d79-4ab4-9a63-2e632d9afbd4	3
318179	ergoloid mesylates, USP 1 MG Oral Tablet	SCD	1344cf98-7d79-4ab4-9a63-2e632d9afbd4	3

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
53489-281-01	53489028101	100 TABLET in 1 BOTTLE, PLASTIC (53489-281-01)	100 tablet	1991-10-31	0000-00-00	No	No	Current
53489-281-02	53489028102	50 TABLET in 1 BOTTLE, PLASTIC (53489-281-02)	50 tablet	1991-10-31	0000-00-00	No	No	Current
53489-281-03	53489028103	250 TABLET in 1 BOTTLE, PLASTIC (53489-281-03)	250 tablet	1991-10-31	0000-00-00	No	No	Current
53489-281-05	53489028105	500 TABLET in 1 BOTTLE, PLASTIC (53489-281-05)	500 tablet	1991-10-31	0000-00-00	No	No	Current
53489-281-10	53489028110	1000 TABLET in 1 BOTTLE, PLASTIC (53489-281-10)	1000 tablet	1991-10-31	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
ERGOLOID MESYLATES TABLETS USP (ORAL)	Sun Pharmaceutical Industries, Inc. \| Frontida BioPharm, Inc.	2017-11-22	HUMAN PRESCRIPTION DRUG LABEL	4
ERGOLOID MESYLATES TABLETS USP (ORAL)	Carilion Materials Management	2016-08-04	HUMAN PRESCRIPTION DRUG LABEL	3